Skip to main content
Clinical Trials/NCT01778374
NCT01778374UnknownNot Applicable

Mater _Bronx Rapid HIV Testing Project. Prospective Randomised Trial of Recruitment Methods in Implementation of a HIV Screening Programme in the Emergency Department.

University College Dublin1 site in 1 country17,000 target enrollmentStarted: September 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
17,000
Locations
1
Primary Endpoint
Number of patients agreeing to undergo a HIV screening test in the Emergency Department

Study Overview

Brief Summary

In the M-BRiHT study we aim to implement a programme of opportunistic HIV screening in the Emergency Department, Mater Misericordiae University Hospital. We hypothesize that such a programme will be acceptable in an Irish setting. We also wish to study the factors that influence test completion or acceptance. We will utilise informative interactive video media via a touch-screen tablet device to provide pre-test counselling and then offer rapid minimally invasive testing with a cotton-bud type swab of the buccal mucosa. In doing so we will to determine absolute numbers of those attending the ED who consent to watching the interactive information video about rapid HIV test screening. We will describe the absolute number and proportion of those who watch the interactive video who subsequently proceed to have the rapid HIV test. The primary aim is to determine the cultural, gender and ethnic factors which influence the completion of such rapid HIV testing with the future objective of maximising test completion in this crucial public health area.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •All adults greater than 18 years of age who present to the Emergency Department, Mater Misericordiae University Hospital
  • •Must have capacity to consent to watch an interactive video tablet device about HIV and HIV screening test.

Exclusion Criteria

  • •HIV positive patients (known previous HIV positive patients).
  • •Acute intoxication in which capacity is impaired
  • •Critically unwell patients who require active or intensive resuscitation.
  • •Acute psychiatric disturbance in which capacity is impaired

Arms & Interventions

No participant choice of counselor

Experimental

Participants in this arm of the study are randomized to an interactive video counselor with no choice of counselor. This is delivered via a touchscreen tablet device.

Intervention: No participant choice of counselor (Other)

Participant choice of counselor

Experimental

Participants in this arm of the study are randomized to an interactive video counselor with a choice of four different counselors. These gender and ethnically diverse counselors are delivered via a touchscreen tablet device.

Intervention: Participant choice of counselor (Other)

Outcomes

Primary Outcomes

Number of patients agreeing to undergo a HIV screening test in the Emergency Department

Time Frame: 24 months

Establish a programme of HIV screening in the Emergency Department, Mater Misericordiae University Hospital. Acceptability of the programme will be judged in terms of absolute numbers of patients consenting to the test.

Secondary Outcomes

  • Absolute number and proportion of HIV positive test results(24 months)
  • To determine the proportions of those who test negative who may fall in to the three month seroconversion window and to determine the proportion of those who return for repeat/multiple HIV tests at three months or other time in the future.(24 months)
  • Absolute numbers of those attending the ED who consent to watching the interactive information video about rapid HIV test screening.(24 months)
  • CD4 count and viral load of newly diagnosed HIV positive patients(24 months)
  • Number of those testing positive who have acute seroconversion illness(24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Patrick Mallon

Associate Dean for Research and Innovation UCD School of Medicine and Medical Sciences, Consultant Infectious Diseases Physician, Head of HIV Molecular Research Group (HMRG).

University College Dublin

Study Sites (1)

Loading locations...

Similar Trials